Medicine Information

Relafen: A New Drug with an Old Danger

Individuals who regularly take Relafen (nabumetone) or other anti-inflammatory medications, either for arthritis, joint pain, or other indications, should be aware of severe adverse health implications that can potentially result from prolonged use. Relafen is usually prescribed for osteoarthritis or rheumatoid arthritis to reduce pain, inflammation, and stiffness, but can also be prescribed for other purposes. Relafen works by reducing the level of hormones in the body that can cause pain and inflammation. In addition to the warnings provided with the packaging of the medication and those related by a physician, there are other important concerns that users of Relafen should know about.

A severe adverse reaction called Stevens-Johnson Syndrome has been linked to use of the drug Relafen. Relafen is in a class of drugs known as nonsteroidal anti-inflammatory medications (NSAIDs) that have been linked to allergic skin reactions, including severe cases such as Stevens-Johnson Syndrome. Other possible allergic reactions include urticaria, dyspnea, anaphylaxis, and the severe symptoms associated with Stevens-Johnson Syndrome.

Stevens-Johnson Syndrome is a severe allergic reaction to certain drugs. In addition to NSAIDs, antibiotics such as sulfonamides, tetracycline, amoxicillin, and ampicillin have been implicated. The symptoms of Stevens-Johnson Syndrome typically begin as some form of upper respiratory infection, including also fever, sore throat, inflammation of the mouth, chills, headaches, aching of the joints, and generally feeling ill. After onset, Stevens-Johnson Syndrome will continue to develop, affecting the various mucous membranes of the body, including the mouth, esophagus, nostrils, eyes, genitals, and anal regions. Lesions may develop and the skin may blister or even detach in severe cases.

If any of these symptoms lead to the belief that the onset of Stevens-Johnson Syndrome is occurring, immediate treatment is imperative. Sufferers of Stevens-Johnson Syndrome should be transported to an emergency room immediately, and will likely be treated in a intensive care burn unit. Even after treatment, long-term effects of Stevens-Johnson Syndrome can include scarring, eye and vision problems, and even death. Some studies predict a 3-15% mortality rate in individuals with Stevens-Johnson Syndrome if left untreated. Any individuals with a known family history of adverse drug reactions, even if minor, should carefully consult with their physicians before taking Relafen or other anti-inflammatory drugs. Above all, it is crucial to be fully aware of all risks associated with the use of any drug.

For more information regarding Relafen (nabumetone)/Stevens-Johnson Syndrome, please click here

This RSS feed URL is deprecated, please update. New URLs can be found in the footers at


Five Winners -- And One Loser -- From Medicine's Big Meeting About Blood
Matthew Herper , Forbes Staff I cover science and medicine, and believe this is biology's century. Johnny Wolf. Kite Founder Arie Belldegrun and BlueBird CEO Nick Leschly talk gene therapy at the Forbes Healthcare Summit. For the past two days, doctors ...


Your smartphone as medicine: Digital therapy is here to stay
The FDA recently approved 1 the first prescription digital therapy, Pear's Reset app 2 and program, which is focused on substance abuse. Others 3 are likely to follow. That means your next trip to the doctor could include a prescription for a mobile ...

Tips for administering medicine to children
As infants and young children grow and gain weight rapidly in early life, a medicine's dose often increases quickly. The dose of a medicine for an infant or child may be greater just several months later, as more weight is gained. Administering the ...

Community Advocate

Metrowest practice offers Functional Medicine
Community Advocate
Hopkinton – If you're sick of feeling unwell and you're looking for a practice that won't just push more pills, you might consider looking into the 4 Better Health Functional Medicine practice in Hopkinton. The practice is owned by Dr. Patti Zub and ...

Cystic Fibrosis News Today

Ontario Researcher Awarded Grant to Develop Precision Medicine Tool for CF
Cystic Fibrosis News Today
Hirota, a respiratory researcher at St. Joseph's and an assistant professor in the department of medicine at McMaster University in Canada, will receive $280,183 over three years under the grant. “Unfortunately, currently approved drugs fail to work in ...

Pharmacists warn of medicine scarcity in Sudan
While medicine prices increase, some life-saving medicines have become scarce in Khartoum and other states. Patients and their attendants complained that medicines have become unaffordable. Some medicines prices have exceeded the price issued that the ...

and more »

RowAnalytics' Giro Initiative Brings Precision Medicine Perspective to Neurodegenerative Disorders
NEW YORK (GenomeWeb) –RowAnalytics, the Martinos Center for Biomedical Imaging, and Envision Genomics are partnering on a new initiative called Giro Health, which they describe as an open initiative in precision medicine that seeks to improve diagnosis ...

Salt Lake Tribune

Commentary: The Tribune was wrong. Medicine often involves a risk to the patient.
Salt Lake Tribune
(Courtesy of the Utah Department of Health) A health department initiative called Talk to Your Pharmacist placed stickers on bottles to prompt prescribers to talk to their pharmacist about the risk of using opioids. By Lynn Webster | For The Tribune ...

UAB News

Celebrating 25 years of psychiatric medicine at UAB
UAB News
CPM groundbreaking ceremony, 1989. Photo provided by UAB Archives.On Sept. 27, 1989, the University of Alabama at Birmingham broke ground for a new building. The Center for Psychiatric Medicine, as the edifice on Sixth Avenue South was to be called ...

Why adding beds might not solve the problem of 'hallway medicine' anytime soon
Beds announced at the end of October to alleviate overcrowding at some hospitals may be slow to come on stream as hiring staff takes time, but some doctors say the move also doesn't address the underlying cause. Dr. Paul Pageau, President of the ...

and more »

Google News

home | site map | Dr. Thad Thomas
© 2006